Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2025-12-25 @ 9:10 PM
Study NCT ID:
NCT01393756
Status:
COMPLETED
Last Update Posted:
2023-12-05
First Post:
2011-07-04
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Revlimid Dose 25 mg in Association With (R-CHOP) in the Treatment Follicular Lymphoma
Sponsor:
The Lymphoma Academic Research Organisation
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
R2-CHOP2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |